About Orion

Orion is a globally operating Nordic pharmaceutical company – a builder of well-being. We draw on our century-long experience in healthcare while keeping our sights firmly set on future innovations to support you every step of your way.

We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. The core therapy areas of our pharmaceutical R&D are oncology and pain.

Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others.

Orion strategy 2024–2028: The road is open for growth through well-being

By the 2030s, Orion will be a truly global, innovative, and patient-focused pharmaceutical company that serves societies and helps change patients’ lives across the globe.

Our main therapy areas

Our products

R&D pipeline

Orion’s pharmaceutical R&D focuses on oncology and pain.

View all our clinical studies

Our purpose and values

Our Nordic heritage

Join us!

Your work builds well-being, drives innovation and impacts millions of lives around the world.

Visit our careers site 

Sustainability Statement 2024

Sustainability statement as part of the Report by the Board of Directors 2024 

Procurement at Orion

We procure materials, products and services for the needs of our production and other functions from a network of over 6000 suppliers in roughly 50 countries.

Our locations

Visit global site 

What are you looking for?

About Orion

Orion strategy 2024–2028: The road is open for growth through well-being

Our business

Where we are

Corporate Governance